Joint Letter to the Senate Judiciary Committee Supporting the Markup of the CREATES Act

Joint letter to the Senate Judiciary Committee supporting the markup of the CREATES Act.

U.S. Senate; United States Senate; Senate Judiciary Committee; Judiciary Committee; Committee on the Judiciary; Sen. Charles Grassley; Sen. Diane Feinstein; Creating and Restoring Equal Access to Samples Act; CREATES Act; S. 974; Health and Human Services; HHS; Food and Drug Administration; FDA; Alex Azar; Scott Gottlieb; samples; prescription drugs; prescription drug prices; generic drugs; biologics; biologicals; biosimilars; low-cost prescription drugs; brand-name prescription drugs; drug manufacturers; pharmaceutical companies; pharma; rising costs of prescription drugs; patient access to prescription drugs; Risk Evaluation and Mitigation Strategies; REMS; Elements to Assure Safe Use; ETASU; prescription drug safety programs and protocols; medications.

Thu, 06/07/2018 - 10:44 AM EDT

Thu, 06/07/2018 - 11:37 AM EDT

3

joint_letter_to_senate_judiciary_committee_supporting_creates_act_markup_2018.pdf

{"CreationDate":"2018-06-07T10:44:27-04:00","Creator":"Microsoft\u00ae Word 2013","Keywords":"U.S. Senate; United States Senate; Senate Judiciary Committee; Judiciary Committee; Committee on the Judiciary; Sen. Charles Grassley; Sen. Diane Feinstein; Creating and Restoring Equal Access to Samples Act; CREATES Act; S. 974; Health and Human Services; HHS; Food and Drug Administration; FDA; Alex Azar; Scott Gottlieb; samples; prescription drugs; prescription drug prices; generic drugs; biologics; biologicals; biosimilars; low-cost prescription drugs; brand-name prescription drugs; drug manufacturers; pharmaceutical companies; pharma; rising costs of prescription drugs; patient access to prescription drugs; Risk Evaluation and Mitigation Strategies; REMS; Elements to Assure Safe Use; ETASU; prescription drug safety programs and protocols; medications.","ModDate":"2018-06-07T11:37:23-04:00","Producer":"Microsoft\u00ae Word 2013","Title":"Joint Letter to the Senate Judiciary Committee Supporting the Markup of the CREATES Act","Pages":3,"xmp:createdate":"2018-06-07T10:44:27-04:00","xmp:creatortool":"Microsoft\u00ae Word 2013","xmp:modifydate":"2018-06-07T11:37:23-04:00","xmp:metadatadate":"2018-06-07T11:37:23-04:00","pdf:producer":"Microsoft\u00ae Word 2013","pdf:keywords":"U.S. Senate; United States Senate; Senate Judiciary Committee; Judiciary Committee; Committee on the Judiciary; Sen. Charles Grassley; Sen. Diane Feinstein; Creating and Restoring Equal Access to Samples Act; CREATES Act; S. 974; Health and Human Services; HHS; Food and Drug Administration; FDA; Alex Azar; Scott Gottlieb; samples; prescription drugs; prescription drug prices; generic drugs; biologics; biologicals; biosimilars; low-cost prescription drugs; brand-name prescription drugs; drug manufacturers; pharmaceutical companies; pharma; rising costs of prescription drugs; patient access to prescription drugs; Risk Evaluation and Mitigation Strategies; REMS; Elements to Assure Safe Use; ETASU; prescription drug safety programs and protocols; medications.","xmpmm:documentid":"uuid:fea5209a-2360-4d71-afb7-cb12eecea99e","xmpmm:instanceid":"uuid:0c88b52a-5e91-4c14-b6c8-b4077e22da4c","dc:format":"application\/pdf","dc:title":"Joint Letter to the Senate Judiciary Committee Supporting the Markup of the CREATES Act","dc:creator":"","dc:subject":["U.S. Senate","United States Senate","Senate Judiciary Committee","Judiciary Committee","Committee on the Judiciary","Sen. Charles Grassley","Sen. Diane Feinstein","Creating and Restoring Equal Access to Samples Act","CREATES Act","S. 974","Health and Human Services","HHS","Food and Drug Administration","FDA","Alex Azar","Scott Gottlieb","samples","prescription drugs","prescription drug prices","generic drugs","biologics","biologicals","biosimilars","low-cost prescription drugs","brand-name prescription drugs","drug manufacturers","pharmaceutical companies","pharma","rising costs of prescription drugs","patient access to prescription drugs","Risk Evaluation and Mitigation Strategies","REMS","Elements to Assure Safe Use","ETASU","prescription drug safety programs and protocols","medications."]}

2018